Mabion SA - ESG Rating & Company Profile powered by AI
Check the bottom of this webpage for potential risks for Mabion SA based on sector, location and size. The ESG score for Mabion SA represents its transparency towards the UN SDGs. The page includes a questions and answers section for Mabion SA.
Mabion SA in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.9; made up of an environmental score of 5.3, social score of 6.4 and governance score of 6.0.
5.9
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
498 | Redx Pharma PLC | 6.0 | High |
498 | Vimta Labs Ltd | 6.0 | High |
521 | Mabion SA | 5.9 | High |
521 | Cellink AB | 5.9 | High |
521 | Celon Pharma SA | 5.9 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Mabion SA have an accelerator or VC vehicle to help deliver innovation?
Does Mabion SA disclose current and historical energy intensity?
Does Mabion SA report the average age of the workforce?
Does Mabion SA reference operational or capital allocation in relation to climate change?
Does Mabion SA disclose its ethnicity pay gap?
Does Mabion SA disclose cybersecurity risks?
Does Mabion SA offer flexible work?
Does Mabion SA have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Mabion SA disclose the number of employees in R&D functions?
Does Mabion SA conduct supply chain audits?
Does Mabion SA disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Mabion SA conduct 360 degree staff reviews?
Does Mabion SA disclose the individual responsible for D&I?
Does Mabion SA disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Mabion SA disclose current and / or historical scope 2 emissions?
Does Mabion SA disclose water use targets?
Does Mabion SA have careers partnerships with academic institutions?
Did Mabion SA have a product recall in the last two years?
Does Mabion SA disclose incidents of discrimination?
Does Mabion SA allow for Work Councils/Collective Agreements to be formed?
Has Mabion SA issued a profit warning in the past 24 months?
Does Mabion SA disclose parental leave metrics?
Does Mabion SA disclose climate scenario or pathway analysis?
Does Mabion SA disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Mabion SA disclose the pay ratio of women to men?
Does Mabion SA support suppliers with sustainability related research and development?
Does Mabion SA disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Mabion SA reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Mabion SA involved in embryonic stem cell research?
Does Mabion SA disclose GHG and Air Emissions intensity?
Does Mabion SA disclose its waste policy?
Does Mabion SA report according to TCFD requirements?
Does Mabion SA disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Mabion SA disclose energy use targets?
Does Mabion SA disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Mabion SA have a policy relating to cyber security?
Have a different question?
Potential Risks for Mabion SA
These potential risks are based on the size, segment and geographies of the company.
Mabion S.A., a biotechnology company, engages in the development of various biotech drugs based on monoclonal antibody technology in Poland. The company develops, produces, and sells medicines for the treatment of neoplastic, autoimmune, metabolic, and neurological diseases. Its products include MabionCD20 and MabionHER2. The company was founded in 2007 and is based in Konstantynów Lódzki, Poland.